|
|
|
|
||
Re: Recent Merck acquisitionWith excellent Top line data that hits the primary endpoint i think it is likely there will be a a bidding war for both RVX and Zenith , The interest in epigenetics is just the beginning, Just IMO, |
return to message board, top of board |